Pierce, Mackenzie
Huang, Yongyang
Lin, Allen
Franco Nitta, Carolina
Kuksin, Dmitry
Lin, Bo
Chan, Leo Li-Ying
Article History
Received: 11 December 2023
Accepted: 15 January 2024
First Online: 31 January 2024
Declarations
:
: The authors MP, YH, AL, CFN, DK, BL, and LLC declare competing financial interests. The work performed in the manuscript is for reporting on applications of an instrument from Revvity Health Sciences, Inc. (an indirect parent company of Nexcelom Biosciences, LLC.). The performed experiment is to demonstrate a multiplex fluorescence imaging methods for identifying early- and late-stage apoptosis.
: Not applicable.